FDA Drug Safety Office Is “Separate, But Unequal,” Senate Committee Says
Executive Summary
A Senate committee investigation into FDA's handling of pediatric suicidality concerns with antidepressant drugs is focusing on the "unequal" status of the Office of Drug Safety and the Office of New Drugs
You may also be interested in...
FDA Office Of Drug Safety Acting Director Is Ralph Lillie
FDA Emergency Preparedness Officer Ralph Lillie is serving as acting director of the Office of Drug Safety in the Center for Drug Evaluation & Research as of Jan. 23
FDA Office Of Drug Safety Acting Director Is Ralph Lillie
FDA Emergency Preparedness Officer Ralph Lillie is serving as acting director of the Office of Drug Safety in the Center for Drug Evaluation & Research as of Jan. 23
Vioxx Hearing May Be Sign Of Things To Come Under Medicare Rx
The Senate Finance Committee should continue to review FDA's drug safety procedures in light of the upcoming expansion of the Medicare program, Ranking Democrat Max Baucus (D-Mont.) maintained during the committee's Nov. 18 hearing on Vioxx